RxDoctor Payments Data

Wade Anderson, PA

Family Health · Gunnison, UTNPI 1578749123

Payments from drug & device makers

$297in general payments, 2019–2025

Across 17 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$133
  • Pfizer$40
  • Sanofi Pasteur Inc.$18
  • Merck$17
  • GSK$16
  • Neurelis, Inc.$15
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$297100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few family health providers in Utahto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$93,228
Medicare patients
255
Services billed
3,266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban146$102,170
MounjaroTirzepatide47$50,427
OzempicSemaglutide47$44,365
TradjentaLinagliptin23$11,887
MyrbetriqMirabegron13$11,527
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,441
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$11,211
JardianceEmpagliflozin11$11,169
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$7,942
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen211$7,284
Xtampza ErOxycodone Myristate12$6,909
Omeprazole403$6,675
GlyxambiEmpagliflozin/Linagliptin11$6,526
Celecoxib180$5,976
Levothyroxine Sodium531$5,551

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$40$102,170146 claims
Novo NordiskOzempic$14$44,36547 claims
Boehringer IngelheimTradjenta, Jardiance, Glyxambi$14$29,58245 claims
GSKTrelegy Ellipta$16$11,44118 claims
AbbVieSynthroid$133$1,96026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few family health providers in Utahon file to place this against a meaningful peer group, so we don't.

Other family health in Gunnison

Where these figures come from

Is this you, or does something look wrong? →